Could hyperandrogenism in PCOS be cardioprotective?

Click here to read the cover story, "Longer studies, funding needed to address ‘substantial knowledge gaps’ on PCOS-related CVD"
The hyperandrogenic phenotype of polycystic ovary syndrome is the one most closely related to the things we think are “bad” for cardiovascular disease — obesity, insulin resistance — and those seem to be the driving factors of CVD risk. We also see examples of elevated CV risk in the setting of higher androgen levels in postmenopausal women and transgender men prescribed gender-affirming hormone therapy.
At the time of the menopause

Click here to read the cover story, «Longer studies, funding needed to address ‘substantial knowledge gaps’ on PCOS-related CVD»
The hyperandrogenic phenotype of polycystic ovary syndrome is the one most closely related to the things we think are “bad” for cardiovascular disease — obesity, insulin resistance — and those seem to be the driving factors of CVD risk. We also see examples of elevated CV risk in the setting of higher androgen levels in postmenopausal women and transgender men prescribed gender-affirming hormone therapy.
At the time of the menopause